Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 18Colonic Neoplasms 18Stomach Neoplasms 13Ovarian Neoplasms 10Neoplasms 5Gastrointestinal Stromal Tumors 5Carcinoma, Hepatocellular 5Peritoneal Neoplasms 4Endometrial Neoplasms 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Prostatic Neoplasms 2Neoplastic Cells, Circulating 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Venous Thrombosis 1Uterine Neoplasms 1Urinary Incontinence 1Surgical Wound Infection 1Sexual Dysfunction, Physiological 1Robotic 1Polycystic Ovary Syndrome 1Pancreatic Neuroendocrine Tumors 1

Interventions

Carboplatin 5Paclitaxel 4pembrolizumab 3Educational Status 3niraparib 2anlotinib 2Therapeutic Touch 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy 2Pemetrexed 2Palliative Care 2Nivolumab 2Methods 2Interviews as Topic 2Gemcitabine 2Early Intervention, Educational 2Bevacizumab 2temsirolimus 1rucaparib 1relacorilant 1olaparib 1nintedanib 1nilotinib 1liposomal doxorubicin 1lenvatinib 1fosaprepitant 1atezolizumab 1argatroban 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡